Latest News about Commentary
Recent news which mentions Commentary
   Vista's Robert Smith: How to prevent AI from further widening the racial wealth gap
   
  
  October 29, 2024
  From CNBC.com News
 
   Top Wall Street analysts are upbeat on these dividend stocks
   
  
  October 27, 2024
  From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 
   D.E. Shaw, Mantle Ridge zero in on key fixes to build shareholder value at Air Products
   
  
  October 19, 2024
  From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 
   ValueAct takes a stake in Sanwa. How the activist can make a good company into a great one
   
  
  September 28, 2024
  From CNBC.com News
 
   Op-ed: The UK's budget problems date back to the 2008 financial crisis
   
  
  September 24, 2024
  From CNBC.com News
 
   Top Wall Street analysts find these stocks promising for the long haul
   
  
  September 22, 2024
  From CNBC.com News
 
   Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors
   
  
  September 17, 2024
  From CNBC.com News
 
   Top Wall Street analysts pick these dividend stocks for attractive returns
   
  
  September 15, 2024
  From CNBC.com News
 
   Voss Capital wants to maximize shareholder value at International Money Express. How it may play out
   
  
  September 14, 2024
  From CNBC.com News
 
   Top Wall Street analysts are bullish on the potential of these 3 stocks
   
  
  September 08, 2024
  From CNBC.com News
 
   Activist Ancora joins investors’ calls for a strategic review at Forward Air. Here’s what may happen next
   
  
  September 07, 2024
  From CNBC.com News
 
   Top Wall Street analysts are bullish on these 3 dividend-paying stocks
   
  
  September 01, 2024
  From CNBC.com News
 From CNBC.com News
 
   Op-ed: The case for a 40-year mortgage
   
  
  August 20, 2024
  From CNBC.com News
 From CNBC.com News
 
   Top Wall Street analysts are bullish on these dividend stocks
   
  
  August 11, 2024
  From CNBC.com News
 
   Activist Oasis suggests three steps to build shareholder value at embattled Kobayashi Pharmaceutical
   
  
  August 10, 2024
  From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.